Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

  1. Manso, L.
  2. Hernando, C.
  3. Galán, M.
  4. Oliveira, M.
  5. Cabrera, M.A.
  6. Bratos, R.
  7. Rodríguez, C.A.
  8. Ruiz-Borrego, M.
  9. Blanch, S.
  10. Llombart-Cussac, A.
  11. Delgado-Mingorance, J.I.
  12. Álvarez-Busto, I.
  13. Gallegos, I.
  14. González-Cortijo, L.
  15. Morales, S.
  16. Aguirre, E.
  17. Hernando, B.A.
  18. Ballesteros, A.
  19. Alés-Martínez, J.E.
  20. Reboredo, C.
  21. Oltra, A.
  22. González-Cao, M.
  23. Santisteban, M.
  24. Malón, D.
  25. Echeverría, I.
  26. García-Garre, E.
  27. Vega, E.
  28. Servitja, S.
  29. Andrés, R.
  30. Robles, C.E.
  31. López, R.
  32. Galve, E.
  33. Echarri, M.J.
  34. Legeren, M.
  35. Moreno, F.
  36. Show all authors +
Journal:
Breast

ISSN: 1532-3080,  0960-9776

Year of publication: 2020

Volume: 54

Pages: 286-292

Type: Article

DOI: 10.1016/J.BREAST.2020.11.005 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus